Outcomes of Treatment Using the ERMI Shoulder Flexionater ®
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: High Intensity Stretch Device.
- Who it may be relevant to
- Registry conditions: Adhesive Capsulitis of Shoulder. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Outcomes of Treatment Using the ERMI Shoulder Flexionater®
Overview
Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device. Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device. Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.
Detailed description
Study 1 - Adhesive Capsulitis Study (AC)
Objective: The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
1. Prospective randomized control trial 2. Sample size - 110 patients 3. Study Groups:
1. Group I - Physical Therapy Only 2. Group II - Flexionater® only 3. Group III - Flexionater® and Physical Therapy 4. Length of study - 2-year follow-up from last enrolled patient
Study 2 - Postoperative Shoulder Stiffness Study (POS)
Objective: The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.
1. Prospective randomized control trial 2. Sample size - 90 enrolled patients 3. Study Groups:
1. Group I - Physical Therapy only 2. Group II - Flexionater® only 3. Group III - Flexionater® and Physical Therapy 4. Length of study - 2-year follow-up from last enrolled patient
Study 3 - Secondary Surgery Study (SAM)
Objective: The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
1. Prospective randomized control trial 2. Sample size - 10 enrolled patients 3. Study Groups:
1. Group I Physical Therapy Only 2. Group II - - Flexionater® only 3. Group III - Flexionater® and Physical Therapy 4. Length of study - 2-year follow-up from last enrolled patient
Interventions
- Device High Intensity Stretch Device
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Primary outcome measures
- Shoulder Range of Motion Improvement [Time frame: 3 months]
- Shoulder Range of Motion [Time frame: 6 months]
- Shoulder Range of Motion [Time frame: 12 months]
- Shoulder Range of Motion [Time frame: 24 months]
- Shoulder Range of Motion [Time frame: 6 weeks]
- Shoulder Range of Motion [Time frame: baseline]
- VAS (Visual Analog Scale) Pain Score [Time frame: 3 months]
- VAS Pain Score [Time frame: 6 weeks]
- VAS Pain Score [Time frame: 6 months]
- VAS Pain Score [Time frame: 12 months]
Secondary outcome measures (9)
- SST [Time frame: Baseline]
- SST [Time frame: 3 month]
- SST [Time frame: 6 weeks]
- SST [Time frame: 6 months]
- SST [Time frame: 12 months]
- SST [Time frame: 24 months]
- Device Compliance Questionnaire (if applicable) [Time frame: 6 weeks]
- Device Compliance Questionnaire (if applicable) [Time frame: 3 months]
- Device Compliance Questionnaire (if applicable) [Time frame: 6 months]
Eligibility criteria
For Study Group 1- Adhesive Capsulitis (AC)
Inclusion criteria
- Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients
Exclusion criteria
- a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder
For Study Group 2 - Postoperative Shoulder Stiffness Study (POS)
Inclusion criteria
c. Is not recovering normally based on objective criteria set for screening process i. Step 1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii. Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of follow-up?
- < 15 degrees external rotation with arm at side at 6 weeks post-op
- OR < 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that meet inclusion criteria and assign group
Exclusion criteria
a. Revision surgery b. Infection c. Rheumatoid arthritis
7\. Procedures included
- Shoulder arthroscopic procedures (29827, 29828, 29823,29824, 29826)
- ORIF Humerus fracture (23615)
For Study Group 3, Secondary Surgery Study (SAM)
Inclusion criteria
- Underwent a manipulation under anesthesia or a lysis of adhesions procedure
Exclusion criteria
a. Infection b. Rheumatoid arthritis c. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder
7\. Procedures included
- Manipulation under anesthesia (23700)
- Lysis of adhesions (29825)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Foundation for Orthopaedic Research and Education — Tampa
Publications
- Teytelbaum DE, Kumar NS, Dent CS, Neaville S, Warren DH, Simon P, Baker CE. Efficacy of a high-intensity home stretching device and traditional physical therapy in non-operative management of adhesive capsulitis - a prospective, randomized control trial. BMC Musculoskelet Disord. 2024 Apr 20;25(1):305. doi: 10.1186/s12891-024-07448-4. PMID 38643086
Identifiers
NCT: NCT05384093 · FORE AC 2019